FDA Inspection
The Tender CorporationThe Tender Corporation – FDA Inspection, Jun 7, 2018
Record Details
This FDA Inspection record concerns The Tender Corporation, with an inspection on June 7, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6b03429e-84b6-4d23-90ff-26ed2418e0ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055369
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.160(b)(4)Establishment of calibration procedures
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Tender Corporation
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 10, 2026 | Not classified | New England District Office | Drug Quality Assurance |
| April 26, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 25, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for The Tender Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.